Scancell
SEARCH
  • HOME
  • COMPANY
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • PARTNERSHIPS
    • CAREERS
  • VACCINES
    • MODITOPE
      • Modi-1
      • Modi-2
    • IMMUNOBODY
      • SCIB1 & iSCIB1+
      • SCIB2 & iSCIB2
      • COVIDITY
    • VACCINE PUBLICATIONS
  • ANTIBODIES
    • GLYMAB
      • ANTI-GLYCAN MAB
    • AVIDIMAB
    • ANTIBODY PUBLICATIONS
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2022
    • YEAR - 2021
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US
SEARCH
  • NEWS

Scancell welcomes strategic new investor Vulpes Life Sciences Fund

[View interview]

Thursday 13 June 2019 13:00 Categories: Interviews Media Coverage Year - 2019
Previous Post << >> Next Post

Categories

  • AvidiMab (9)
  • Covid-19 (13)
  • GlyMab (2)
  • Immunobody (112)
  • Interviews (11)
  • Media Coverage (43)
  • Modi-1 (41)
  • Modi-2 (4)
  • Moditope (76)
  • News (309)
  • Presentations (6)
  • Regulatory News (276)
  • SCIB1 (136)
  • SCIB2 (22)
  • Webcasts (1)
  • Year - 2014 and older (142)
  • Year - 2015 (15)
  • Year - 2016 (31)
  • Year - 2017 (21)
  • Year - 2018 (42)
  • Year - 2019 (47)
  • Year - 2020 (30)
  • Year - 2021 (20)
  • Year - 2022 (8)
  • Company
  • Overview
  • Board of Directors
  • Management
  • Partnerships
  • Careers
  • Vaccines
  • Moditope
  • Immunobody
  • Vaccine Publications
  • Antibodies
  • GlyMab
  • AvidiMab
  • Antibody Publications
  • Investors
  • Company Profile
  • Advisors
  • Corporate Governance
  • Documents & Presentations
  • Share Information
  • Financial Information
  • Regulatory News
  • News
  • Latest News
  • Contact Us
  • Privacy

News updates

Sign up for news updates to stay up to date with Scancell

Privacy & legal notes ©Copyright Scancell 2022